๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A turn of the sulfatide in Alzheimer's disease

โœ Scribed by Michael C. Irizarry


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
42 KB
Volume
54
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The electroretinogram in Alzheimer's dis
โœ Vicki E. Pollock; Lon S. Schneider ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 243 KB ๐Ÿ‘ 2 views

We agree with Dr Jellinger's overall point that several different pathological lesions, alone or in combination, may ac-

The end of Alzheimer's disease?
โœ John C. S. Breitner ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 1 views

The title of this work reveals my conviction that at least a partial solution to the tragedy of Alzheimer's disease (AD) is likely in the next 20 years. The double meaning of the title is meant to introduce two themes. First, there is a ยฎnite risk period for AD, which has its end in extreme old age.

Advances in the drug treatment of Alzhei
โœ B. E. Leonard ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 133 KB ๐Ÿ‘ 2 views

There are two main approaches to the treatment of Alzheimer's disease. The ยฎrst approach is to prevent the neurodegenerative changes that ultimately cause irreversible damage to the brain. As the excessive formation of betaamyloid protein appears to play a primary role in the neurodegenerative proce

Measurement of progression in Alzheimer'
โœ Douglas J. Gelb ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB ๐Ÿ‘ 1 views

Patients with Alzheimer's disease (AD) and their families must confront two fundamental truths. First, AD is a uniformly progressive disease that ultimately results in debilitating cognitive impairment. Second, although there is now evidence that some medications may produce transient improvement or